Transplant Oncology: Cellular Therapies for Transplant Patients
Virtual EventCourse Overview Solid organ transplant recipients are at 3-10 times higher risk of cancer compared to non-transplant patients, due to long-standing immunosuppression. Cellular therapies, such as CAR-T or virus-specific T […]